Current issues in the management of actinic keratosis - 09/12/12
Abstract |
Actinic keratoses are common sun-induced skin lesions that should be treated to prevent the development of nonmelanoma skin cancer. Although cryotherapy is commonly used to treat individual lesions, it fails to address the actinically damaged field of neighboring sun-damaged skin, which is more effectively treated by field therapies to clear both visible and subclinical lesions. Most topical treatments require prolonged use and cause an inflammatory response that limits tolerability and adherence. Education is essential to teach patients about the chronic nature of actinic keratosis, the risk of nonmelanoma skin cancer, and the importance of correct use of topical medications. The addition of nonphysician clinicians to dermatologic practices provides a valuable source of education, treatment, and follow-up care to the management of actinic keratosis.
Le texte complet de cet article est disponible en PDF.Key words : actinic keratosis, combination therapy, nonphysician clinicians, nurse practitioner, physician assistant, quality of life, therapeutic management, treatment adherence
Abbreviations used : AE, AK, FU, NP, PA, QoL, SCC
Plan
Publication of this article was supported by a grant from LEO Pharma Inc., Parsippany, NJ. |
|
Disclosure: Dr Ceilley is a consultant for Galderma, Graceway Pharmaceuticals, GlaxoSmithKline, and LEO Pharma Inc. Dr Jorizzo is an advisor for Amgen, LEO Pharma Inc, and Warner Chilcott. |
|
Reprint requests: Panagiotis Zografos, LEO Pharma Inc., 1 Sylvan Way, Parsippany, NJ 07054. E-mail: panagiotis.zografos@leo-pharma.com. |
Vol 68 - N° 1S1
P. S28-S38 - janvier 2013 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?